Summary
89 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 26% a year over the last 3 years.
- Out of every 100 CAD of revenue, 23 CAD is left as net profit.
- The share price is below the Bulios Fair Price.
- It has raised its dividend 5 years in a row and pays out only 25% of profit.
What to watch
- It missed profit estimates 4 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapPrice against the Bulios Fair Price
P/E against the industry (Asset Management)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 6.8 CAD for 1 CAD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (CAD)
Diluted EPS (CAD)
- Analyst estimate
Revenue grew by 7.5% a year over 5 years. Over the last 3 years it grew by 7.5% a year. For the next fiscal year analysts expect revenue to grow by 6.5%. Earnings per share grew by 26% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 CAD of revenue goes
- Cost of sales 42 CAD
- Sales and administration 31 CAD
- Taxes and other 8.1 CAD
- Net profit 23 CAD
Net profit, industry median (Asset Management) 23 CAD
Out of every 100 CAD of revenue, 23 CAD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Moderate, safe- Yield
- 3.63%
- Paid out of profit
- 25%
- Raised in a row
- 5 years
You receive $0.38 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Neutral- Buy 1
- Hold 2
- Sell 0
Today's price within the analysts' price targets
The average target of $23 is 117% above today's price. 33% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.